# Investigation on the Effect of Carnitine Supplement on Gut Microbiota and TMAO Production Capacity

> **NCT02838732** · NA · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 56 (actual)

## Conditions studied

- Dietary Exposure

## Interventions

- **DIETARY_SUPPLEMENT:** L-carnitine supplementation (500 mg per tablet per day, purchased from GNC company)

## Key facts

- **NCT ID:** NCT02838732
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-18
- **Primary completion:** 2017-11-20
- **Final completion:** 2019-10-07
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2023-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02838732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02838732, "Investigation on the Effect of Carnitine Supplement on Gut Microbiota and TMAO Production Capacity". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02838732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*